TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997
TCL Archive New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors June 29, 2001
TCL Archive After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency. May 18, 2007
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012